Phlo raises £10m in Series A funding to expand its digital pharmacy services
The Series A round was led by Thairm Bio to support the expansion of same-day medication delivery across the UK.
Phlo operates a digital pharmacy platform offering same-day prescription delivery services and healthcare infrastructure solutions in the UK.
Phlo has secured £10m in a Series A funding round to expand its same-day medication delivery services and digital infrastructure platform across the UK. The investment was led by family office Thairm Bio and comprises a mix of equity and converted loan notes.
The capital will support the company as it scales operations, grows its team, and expands partnerships with healthcare providers. Phlo previously raised £2m in a 2020 crowdfunding campaign.
Founded in 2019, the Glasgow-based firm operates both a direct-to-consumer digital pharmacy and Phlo Connect, a backend infrastructure service utilized by other healthcare providers.
From the founder
"This round of investment is particularly crucial in helping us scale our offering and realising our vision of establishing Phlo as the market leader in the delivery of next-generation digital pharmacy services right across the UK. We have a very busy roadmap ahead and some incredibly exciting opportunities to take advantage of in 2023 and beyond"
Nadeem Sarwar
Founder and CEO at Phlo
Investor perspective
"Thairm Bio is delighted to lead this investment round, in partnership with a dedicated group of investors, and to support Phlo in their continued expansion across the UK."
Mark Bamforth
Founder, Thairm Bio
Use of funds
- 01Expand into international markets
- 02Scale operations